Cancer BiologybioRxivPreprint
H3 dopaminylation and CaMKII modulate diffuse midline glioma response to CDK9 inhibition
Rebecca L. Murdaugh, Brittany R Eberl, Rosemary U. Richard…·Jamie N. Anastas
This study shows that combining CDK9 inhibitors with neuropsychiatric drugs reduces diffuse midline glioma growth by altering H3 dopaminylation and CaMKII signaling.
DOI 10.64898/2026.04.07.714507